ESC 365 - Clinical experience with subcutaneous furosemide in patients with fluid overload.

HFA Premium Access

Clinical experience with subcutaneous furosemide in patients with fluid overload.

Session: Furosemide 2.0 - Subcutaneous administration of a novel formulation

Topic: Acute Heart Failure

Speaker: Doctor N. Gilotra (Baltimore, US)

Sponsored by scPharmaceuticals, Inc.

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Presentation

About the speaker

Doctor Nisha Gilotra

Baltimore (United States of America)

1 presentation

0 follower

3 more presentations in this session

Health policy and economics related to treatment of fluid overload in heart failure.

Speaker: Doctor N. Desai (New Haven, US)

Rationale for a new furosemide product 50 years after its first introduction.

Speaker: Professor R. De Boer (Groningen, NL)

First experience with a patch infusor for subcutaneous administration of a novel furosemide formulation.

Speaker: Professor J. Udelson (Boston, US)

Access the full session

Furosemide 2.0 - Subcutaneous administration of a novel formulation

Speakers: Doctor N. Gilotra, Doctor N. Desai, Professor R. De Boer, Professor J. Udelson

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

This platform is supported by